MERIDIAN BIOSCIENCE INC - COMMON STOCK (VIVO)

Historical Institutional Holders from Q1 2014 to Q4 2024

All holders as of December 31, 2024
Q4 2024
Type / Class
Equity / COMMON STOCK
Shares, excl. options Q4 2024
1
Holdings value Q4 2024
$34.00
Value change Q4 2024
$0
Grand Portfolio weight change Q4 2024
0%
Number of holders
1
Number of buys Q4 2024
0
Number of sells Q4 2024
0
Average buys Q4 2024 %
0
Average sells Q4 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 1 $34.00 $0 $34.00 1
2024 Q3 1 $34.00 $0 $34.00 1
2024 Q2 1 $34.00 $0 $34.00 1
2024 Q1 1 $34.00 $0 $34.00 1
2023 Q4 1 $34.00 $0 $34.00 1
2023 Q3 1 $34.00 $0 $34.00 1
2023 Q2 1 $34.00 -$49K $34.00 1
2023 Q1 1.49K $49K -$1.37B $33.48 2
2022 Q4 41.4M $1.37B +$30.2M $33.21 216
2022 Q3 40.5M $1.28B -$104M $31.53 193
2022 Q2 44.3M $1.35B +$48.8M $30.42 212
2022 Q1 43M $1.12B +$58.3M $25.96 201
2021 Q4 41.1M $838M -$5.48M $20.40 178
2021 Q3 41M $788M -$35.7M $19.24 177
2021 Q2 43M $953M +$29.3M $22.18 187
2021 Q1 41.3M $1.08B +$67M $26.25 211
2020 Q4 39.2M $732M +$12M $18.69 188
2020 Q3 38.7M $658M -$18.8M $16.98 187
2020 Q2 39.3M $915M +$107M $23.29 189
2020 Q1 35.7M $300M -$14M $8.40 160
2019 Q4 37.1M $362M -$19.4M $9.77 164
2019 Q3 38.9M $368M -$1.79M $9.49 162
2019 Q2 38.9M $462M -$23.8M $11.88 165
2019 Q1 39.8M $701M +$763K $17.61 178
2018 Q4 39.8M $691M +$2.61M $17.36 188
2018 Q3 39.7M $592M +$16.1M $14.90 174
2018 Q2 38.7M $615M +$11.7M $15.90 176
2018 Q1 38.1M $541M -$7.56M $14.20 183
2017 Q4 38.5M $539M +$7.31M $14.00 176
2017 Q3 37.9M $542M +$3.96M $14.30 171
2017 Q2 37.6M $592M +$10M $15.75 169
2017 Q1 37.1M $512M +$48M $13.80 164
2016 Q4 37.6M $665M -$5.29M $17.70 180
2016 Q3 36.6M $706M -$529K $19.29 169
2016 Q2 38.1M $742M -$25.7M $19.50 178
2016 Q1 39.1M $807M +$11.8M $20.61 169
2015 Q4 37.8M $776M +$21.7M $20.52 173
2015 Q3 38.4M $657M -$1.76M $17.10 174
2015 Q2 38.4M $715M +$5.51M $18.64 166
2015 Q1 37.8M $721M +$10.1M $19.08 157
2014 Q4 37.7M $621M -$27.8M $16.46 159
2014 Q3 39.3M $695M -$6.07M $17.69 159
2014 Q2 39.2M $810M +$2.03M $20.64 161
2014 Q1 39.1M $852M -$20.4M $21.79 167